BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 18549684)

  • 41. Serum total renin is elevated in women with polycystic ovarian syndrome.
    Jaatinen TA; Matinlauri I; Anttila L; Koskinen P; Erkkola R; Irjala K
    Fertil Steril; 1995 May; 63(5):1000-4. PubMed ID: 7720907
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [A pilot study of serum anti-Mullerian hormone in diagnosis of polycystic ovary syndrome based on 2012 Chinese polycystic ovary syndrome diagnosis criteria].
    Yang S; Ruan J; Huang W; Tan J; Zhang X; Feng X; Liu D; Fu J; Zhou L; Zhou M
    Zhonghua Fu Chan Ke Za Zhi; 2015 Nov; 50(11):819-24. PubMed ID: 26887768
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Short-term changes in hormonal profiles after laparoscopic ovarian laser evaporation compared with diagnostic laparoscopy for PCOS.
    Hendriks ML; König T; Korsen T; Melgers I; Dekker J; Mijatovic V; Schats R; Hompes PG; Homburg R; Kaaijk EM; Twisk JW; Lambalk CB
    Hum Reprod; 2014 Nov; 29(11):2544-52. PubMed ID: 25267790
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Elevated anti-Mullerian hormone in lean women may not indicate polycystic ovarian syndrome.
    Bradbury RA; Lee P; Smith HC
    Aust N Z J Obstet Gynaecol; 2017 Oct; 57(5):552-557. PubMed ID: 28597496
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Polycystic ovarian morphology and the diagnosis of polycystic ovary syndrome: redefining threshold levels for follicle count and serum anti-Müllerian hormone using cluster analysis.
    Lie Fong S; Laven JSE; Duhamel A; Dewailly D
    Hum Reprod; 2017 Aug; 32(8):1723-1731. PubMed ID: 28854584
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Focus on BMI and subclinical hypothyroidism in adolescent girls first examined for amenorrhea or oligomenorrhea. The emerging role of polycystic ovary syndrome.
    Nezi M; Christopoulos P; Paltoglou G; Gryparis A; Bakoulas V; Deligeoroglou E; Creatsas G; Mastorakos G
    J Pediatr Endocrinol Metab; 2016 Jun; 29(6):693-702. PubMed ID: 27089404
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Polycystic ovaries are common in women with hyperandrogenic chronic anovulation but do not predict metabolic or reproductive phenotype.
    Legro RS; Chiu P; Kunselman AR; Bentley CM; Dodson WC; Dunaif A
    J Clin Endocrinol Metab; 2005 May; 90(5):2571-9. PubMed ID: 15713728
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Serum anti-Mullerian hormone as a surrogate for antral follicle count for definition of the polycystic ovary syndrome.
    Pigny P; Jonard S; Robert Y; Dewailly D
    J Clin Endocrinol Metab; 2006 Mar; 91(3):941-5. PubMed ID: 16368745
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [LH-FSH ratio and Polycystic Ovary Syndrome: A forgotten test?].
    Saucedo de la Llata E; Moraga-Sánchez MR; Romeu-Sarrió A; Carmona-Ruiz IO
    Ginecol Obstet Mex; 2016 Feb; 84(2):84-94. PubMed ID: 27290835
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A simple screening approach for assessing community prevalence and phenotype of polycystic ovary syndrome in a semi-urban population in Sri Lanka.
    Kumarapeli V; Seneviratne Rde A; Wijeyaratne CN; Yapa RM; Dodampahala SH
    Am J Epidemiol; 2008 Aug; 168(3):321-8. PubMed ID: 18550559
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Tissue insulin sensitivity and body weight in polycystic ovary syndrome.
    Marsden PJ; Murdoch AP; Taylor R
    Clin Endocrinol (Oxf); 2001 Aug; 55(2):191-9. PubMed ID: 11531925
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Investigating the potential of clinical and biochemical markers to differentiate between functional hypothalamic amenorrhoea and polycystic ovarian syndrome: A retrospective observational study.
    Abou Sherif S; Newman R; Haboosh S; Al-Sharefi A; Papanikolaou N; Dimakopoulou A; Webber LJ; Abbara A; Franks S; Dhillo WS; Jayasena CN
    Clin Endocrinol (Oxf); 2021 Oct; 95(4):618-627. PubMed ID: 34323305
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Body mass index and gonadotropin hormones (LH & FSH) associate with clinical symptoms among women with polycystic ovary syndrome.
    Esmaeilzadeh S; Andarieh MG; Ghadimi R; Delavar MA
    Glob J Health Sci; 2014 Sep; 7(2):101-6. PubMed ID: 25716399
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The role of serum anti-Müllerian hormone (AMH) in the hormonal diagnosis of polycystic ovary syndrome.
    Casadei L; Madrigale A; Puca F; Manicuti C; Emidi E; Piccione E; Dewailly D
    Gynecol Endocrinol; 2013 Jun; 29(6):545-50. PubMed ID: 23506275
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Free testosterone, luteinizing hormone/follicle stimulating hormone ratio and pelvic sonography in relation to skin manifestations in patients with polycystic ovary syndrome.
    Sharquie KE; Al-Bayatti AA; Al-Ajeel AI; Al-Bahar AJ; Al-Nuaimy AA
    Saudi Med J; 2007 Jul; 28(7):1039-43. PubMed ID: 17603706
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Non-classic adrenal hyperplasia due to the deficiency of 21-hydroxylase and its relation to polycystic ovarian syndrome.
    Pignatelli D
    Front Horm Res; 2013; 40():158-70. PubMed ID: 24002412
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Clinical and biochemical discriminants between functional hypothalamic amenorrhoea (FHA) and polycystic ovary syndrome (PCOS).
    Phylactou M; Clarke SA; Patel B; Baggaley C; Jayasena CN; Kelsey TW; Comninos AN; Dhillo WS; Abbara A
    Clin Endocrinol (Oxf); 2021 Aug; 95(2):239-252. PubMed ID: 33354766
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The independent effects of polycystic ovary syndrome and obesity on serum concentrations of gonadotrophins and sex steroids in premenopausal women.
    Holte J; Bergh T; Gennarelli G; Wide L
    Clin Endocrinol (Oxf); 1994 Oct; 41(4):473-81. PubMed ID: 7955458
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Receiver operating characteristic analysis of the performance of basal serum hormone profiles for the diagnosis of polycystic ovary syndrome in epidemiological studies.
    Escobar-Morreale HF; Asunción M; Calvo RM; Sancho J; San Millán JL
    Eur J Endocrinol; 2001 Nov; 145(5):619-24. PubMed ID: 11720881
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Relationship of GnRH-stimulated LH release to episodic LH secretion and baseline endocrine-metabolic measures in women with polycystic ovary syndrome.
    Patel K; Coffler MS; Dahan MH; Malcom PJ; Deutsch R; Chang RJ
    Clin Endocrinol (Oxf); 2004 Jan; 60(1):67-74. PubMed ID: 14678290
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.